FDA Inspection 1081231 — Vivus, LLC.

Vivus, LLC. — FEI 3000719979

The FDA completed an inspection of Vivus, LLC. on Nov 28, 2018 in Campbell, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 28, 2018
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Campbell, CA (United States)

Additional details

Risk Evaluation and Mitigation Strategies (REMS)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.